FATE THERAPEUTICS INC Capital Expenditures Incurred but Not yet Paid
FATE THERAPEUTICS INC (FATE) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-13
- FATE THERAPEUTICS INC capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$15.00K, a 104.44% decline year-over-year.
- FATE THERAPEUTICS INC capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $15.00K, a 97.71% decline year-over-year.
- FATE THERAPEUTICS INC capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was -$398.00K, a 420.97% decline year-over-year.
- FATE THERAPEUTICS INC capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$595.00K.
- FATE THERAPEUTICS INC capital expenditures incurred but not yet paid for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- FATE THERAPEUTICS INC capital expenditures incurred but not yet paid for fiscal 2024 was $140.00K.
- FATE THERAPEUTICS INC capital expenditures incurred but not yet paid for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- FATE THERAPEUTICS INC capital expenditures incurred but not yet paid for fiscal 2022 was $1.05M, a 75.86% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month | Capital Expenditures Incurred but Not yet Paid 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | -$398.00K derived: sum of 3 quarters · filed 2026-08-13 | -$993.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $15.00K 10-Q · filed 2026-05-13 | -$383.00K derived: sum of 2 quarters · filed 2026-05-13 | -$978.00K derived: sum of 3 quarters · filed 2026-05-13 | -$640.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | -$398.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$993.00K derived: sum of 2 quarters · filed 2026-02-26 | -$655.00K derived: sum of 3 quarters · filed 2026-08-13 | $0.00 10-K · filed 2026-02-26 | |
| 2025-09-30 | -$595.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$257.00K derived: sum of 2 quarters · filed 2026-08-13 | $398.00K 10-Q · filed 2025-11-13 | $522.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $338.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $993.00K 10-Q · filed 2026-08-13 | $1.12M derived: sum of 3 quarters · filed 2026-08-13 | $1.03M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $655.00K 10-Q · filed 2026-05-13 | $779.00K derived: sum of 2 quarters · filed 2026-05-13 | $693.00K derived: sum of 3 quarters · filed 2026-05-13 | $781.00K derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $38.00K derived: sum of 2 quarters · filed 2026-02-26 | $126.00K derived: sum of 3 quarters · filed 2026-02-26 | $140.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.00K derived: sum of 2 quarters · filed 2025-11-13 | $16.00K 10-Q · filed 2025-11-13 | -$152.00K derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $102.00K 10-Q · filed 2025-08-12 | -$66.00K derived: sum of 3 quarters · filed 2025-08-12 | -$510.00K derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $14.00K 10-Q · filed 2025-05-13 | -$154.00K derived: sum of 2 quarters · filed 2025-05-13 | -$598.00K derived: sum of 3 quarters · filed 2025-05-13 | -$598.00K derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | -$168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | -$612.00K derived: sum of 2 quarters · filed 2025-03-05 | -$612.00K derived: sum of 3 quarters · filed 2025-03-05 | $0.00 10-K · filed 2025-03-05 | |
| 2023-09-30 | -$444.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$444.00K derived: sum of 2 quarters · filed 2024-11-12 | $168.00K 10-Q · filed 2024-11-12 | -$765.00K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $612.00K 10-Q · filed 2024-08-13 | -$321.00K derived: sum of 3 quarters · filed 2024-08-13 | $198.00K derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $612.00K 10-Q · filed 2024-05-09 | -$321.00K derived: sum of 2 quarters · filed 2024-05-09 | $198.00K derived: sum of 3 quarters · filed 2024-05-09 | -$1.71M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | -$933.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -$414.00K derived: sum of 2 quarters · filed 2024-02-26 | -$2.32M derived: sum of 3 quarters · filed 2024-02-26 | $1.05M 10-K · filed 2024-02-26 | |
| 2022-09-30 | $519.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$1.39M derived: sum of 2 quarters · filed 2023-11-08 | $1.99M 10-Q · filed 2023-11-08 | $2.74M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | -$1.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.47M 10-Q · filed 2023-08-08 | $2.22M derived: sum of 3 quarters · filed 2023-08-08 | $4.41M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | $3.38M 10-Q · filed 2023-05-03 | $4.13M derived: sum of 2 quarters · filed 2023-05-03 | $6.31M derived: sum of 3 quarters · filed 2023-05-03 | $5.12M derived: sum of 4 quarters · filed 2023-05-03 | |
| 2021-12-31 | $749.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $2.94M derived: sum of 2 quarters · filed 2023-02-28 | $1.75M derived: sum of 3 quarters · filed 2023-02-28 | $4.37M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $998.00K derived: sum of 2 quarters · filed 2022-11-03 | $3.62M 10-Q · filed 2022-11-03 | $3.92M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | -$1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $1.44M 10-Q · filed 2022-08-03 | $1.74M derived: sum of 3 quarters · filed 2023-02-28 | $2.75M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $2.62M 10-Q · filed 2022-05-04 | $2.93M derived: sum of 2 quarters · filed 2023-02-28 | $3.94M derived: sum of 3 quarters · filed 2023-02-28 | $3.77M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | $303.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.31M derived: sum of 2 quarters · filed 2023-02-28 | $1.14M derived: sum of 3 quarters · filed 2023-02-28 | $1.49M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $840.00K derived: sum of 2 quarters · filed 2021-11-04 | $1.18M 10-Q · filed 2021-11-04 | $981.00K derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | -$171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $172.00K 10-Q · filed 2021-08-04 | -$30.00K derived: sum of 3 quarters · filed 2022-02-28 | -$279.00K derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | $343.00K 10-Q · filed 2021-05-05 | $141.00K derived: sum of 2 quarters · filed 2022-02-28 | -$108.00K derived: sum of 3 quarters · filed 2022-02-28 | -$537.00K derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | -$202.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$451.00K derived: sum of 2 quarters · filed 2022-02-28 | -$880.00K derived: sum of 3 quarters · filed 2022-02-28 | $602.00K 10-K · filed 2022-02-28 | |
| 2019-09-30 | -$249.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$678.00K derived: sum of 2 quarters · filed 2020-11-05 | $804.00K 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | -$429.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $1.05M 10-Q · filed 2020-08-05 | |||
| 2019-03-31 | $1.48M 10-Q · filed 2020-05-11 | ||||
| 2018-12-31 | $37.00K 10-K · filed 2021-02-24 | $200.00K 10-K · filed 2019-03-05 | |||
| 2017-12-31 | $48.00K 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |